Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pivotal HEAT Study of ThermoDox in primary liver cancer reaches target for unblinding

Nov. 12, 2012

Daiichi Sankyo submits supplemental NDA for Topotecin in Japan

Nov. 12, 2012

VS-5584 treatment inhibits cancer stem cells in vitro and in vivo

Nov. 12, 2012

U.S. team prepares novel MAbs for cancer

Nov. 12, 2012

Scientists at Vertex Pharmaceuticals patent new protein kinase inhibitors

Nov. 9, 2012

Nektar Therapeutics synthesizes promising thymidylate synthase inhibitor

Nov. 9, 2012

Sloan-Kettering Institute for Cancer Research patents new HSP 90 inhibitors

Nov. 9, 2012

IMA-901 receives FDA orphan designation, phase III study completes enrollment

Nov. 9, 2012

T-3256336 proven to be a highly effective inhibitor of tumor growth in vivo

Nov. 9, 2012

FDA grants fast track status for etirinotecan pegol in metastatic breast cancer

Nov. 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...